ArticleActa pharmaceutica Sinica. B2025

A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA-PB1 interactions and modulating host macrophage inflammation.

Kunyu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.